The Presidency of the Swiss Federal Institute of Technology in Lausanne (EPFL), the Dean of the EPFL School of Life Sciences, and the executive board of Debiopharm Group are pleased to invite applications for the
Debiopharm Life Sciences Award 2009
In 2009 this annual award will be given to a young investigator in the field of Biology and Immunology of Infection. It will be awarded on the occasion of the Annual EPFL Life Science Symposium to be held from September 2 to 4, 2009.
The Award is sponsored by Debiopharm Group, a Swiss biopharmaceutical company that focuses on drug development. The prize will honor a European investigator below the age of forty, who has made outstanding contributions to Infection Biology. It consists of a total of 100'000 Swiss Francs (approx. 87'000 US$). One half of this amount is a personal reward and the other half will contribute to support her/his research.
Candidates are invited to submit their application. A Jury of internationally renowned scientific experts will evaluate the applications.
The dossier should comprise:
- a one-page endorsement letter describing the importance of the nominee's contribution to the Biology and Immunology of Infection,
- her/his curriculum vitae,
- her/his list of publications,
- a one-page outline of her/his plans for future research.
The deadline for submitting nominations is April 15, 2009 and all dossiers are to be sent, exclusively in electronic format and in the form of one single "pdf" file, to:
Harald Hirling
mailto:harald.hirling@epfl.ch